TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Michael S. Weiss$2.2B
Market Cap • 22/04/20241993
(há 31 anos)
1995
(29 years ago)
NASDAQ
Listagem
Morrisville
Sede • North Carolina226
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
TGTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.